Table 2.

Correlation of HDAC mRNA expression with lymph node status of GC patients.

HDACs	Lymph node status	Cases	HR (95%CI)	P value
HDAC1	Negative	76	0.4 (0.17–0.92)	.025∗
	Positive	437	0.54 (0.41–0.7)	.0000028∗
HDAC2	Negative	76	2.44 (0.72–8.28)	.14
	Positive	437	0.84 (0.64–1.1)	.12
HDAC3	Negative	76	1.49 (0.66–3.4)	.34
	Positive	437	1.2 (0.92–1.56)	.18
HDAC4	Negative	76	1.9 (0.82–4.38)	.13
	Positive	437	1.79 (1.36–2.36)	.000026∗
HDAC5	Negative	76	0.54 (0.22–1.32)	.17
	Positive	437	1.74 (1.34–2.27)	.000026∗
HDAC6	Negative	76	2.93 (1.26–6.85)	.0094∗
	Positive	437	1.83 (1.41–2.38)	.0000051∗
HDAC7	Negative	76	1.77 (0.69–4.49)	.23
	Positive	437	1.55 (1.18–2.04)	.0014∗
HDAC8	Negative	76	1.84 (0.8–4.21)	.14
	Positive	437	1.58 (1.2–2.06)	.00084∗
HDAC9	Negative	76	3.56 (1.39–9.12)	.0049∗
	Positive	437	1.28 (0.95–1.71)	.1
HDAC10	Negative	76	1.85 (0.62–5.54)	.26
	Positive	437	1.91 (1.45–2.52)	.0000028∗
HDAC11	Negative	76	2.08 (0.91–4.73)	.075
	Positive	437	1.4 (1.05–1.86)	.02∗

GC = gastric cancer; HDACs = histone deacetylases; HR = hazard ratio.

^∗P value < .05.